Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
MEK1/2 和 PI3K 或 PDGFR 的联合激酶抑制剂对颅内三阴性乳腺癌有效
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/nox052
Van Swearingen Amanda E D, Sambade Maria J, Siegel Marni B, Sud Shivani, McNeill Robert S, Bevill Samantha M, Chen Xin, Bash Ryan E, Mounsey Louisa, Golitz Brian T, Santos Charlene, Deal Allison, Parker Joel S, Rashid Naim, Miller C Ryan, Johnson Gary L, Anders Carey K